Catalyst Funds Management Pty LTD Eledon Pharmaceuticals, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $382 Billion
- Q1 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 13,620 shares of ELDN stock, worth $39,089. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,620Holding current value
$39,089% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
87Shares Held
37.3MCall Options Held
10.5KPut Options Held
66.8K-
Bvf Inc San Francisco, CA6.29MShares$18.1 Million0.94% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$10.2 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$8.48 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$6.68 Million1.01% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.31MShares$6.62 Million2.06% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $39.5M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...